Personalising airway clearance in chronic lung disease by McIlwainne, Maggie et al.
For Review Only - ERR
 
 
 
 
 
 
Personalising airway clearance in chronic lung disease 
 
 
Journal: European Respiratory Review 
Manuscript ID ERR-0086-2016.R2 
Manuscript Type: Review 
Date Submitted by the Author: 20-Nov-2016 
Complete List of Authors: McIlwaine, Maggie; BC's Children's Hospital, Physiotherapy; University of 
British Columbia, Physical Therapy 
Bradley, Judy; Queen's University Belfast Faculty of Medicine Health and 
Life Sciences, School of Medicine, Dentistry, and Biomedical Sciences 
Elborn, J; Queens University of Belfast, Centre for Experimental Medicine ; 
National Heart and Lung Institute, Imperial College and Royal Brompton 
Hospital 
Moran, Fidelma; University of Ulster Faculty of Life and Health Sciences, 
Life and Health Sciences 
Keyword: 
lung physiology, Airway clearance techniques, Chronic lung diseases, 
Personalised medicine, Physiotherapy 
  
 
 
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
European Respiratory Review
For Review Only - ERR
 
August 18
th
 2016. 
 
To the Editors of the European Respiratory Review 
RE:  Personalising airway clearance in chronic lung disease. 
 
Authors: Maggie McIlwaine, Judy Bradley, Stuart Elborn and Fidelma Moran. 
 
We are pleased to submit the manuscript titled, “Personalising airway clearance in chronic lung 
disease” for consideration as a, “State of the Art Review” for publication in European 
Respiratory Review. 
This review describes a framework for providing a personalised approach to selecting the most 
appropriate airway clearance technique (ACT) for the individual patient. It is based on a 
synthesis of the physiological evidence that supports the modulation of ventilation and expiratory 
airflow as a means of assisting airway clearance.  This provides the basis for clinical reasoning in 
selecting the most appropriate ACT. 
 
The authors of this paper, believe that this review will have an impact on how clinicians 
personalise airway clearance techniques in clinical practice in patients with bronchiectasis and 
other chronic suppurative lung diseases from any cause including CF. While a few papers have 
attempted to describe the physiological theories on which airway clearance techniques are based, 
this is the first paper to collate the physiological evidence to support these theories and to 
provide clinical reasoning for use of the different approaches to airway clearance. 
 
Thank-you for your consideration. 
Maggie McIlwaine 
Yours 
Maggie McIlwaine MCSP, PhD. 
Cardiorespiratory Clinical Specialist 
Clinical Associate Professor 
University of British Columbia 
Rm K3-104 
BC Children’s Hospital 
4480 Oak street. 
Vancouver, BC 
V6H 3V4. Canada 
Email mmcilwaine@cw.bc.ca 
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ABSTRACT    
This review describes a framework for providing a personalised approach to selecting the 
most appropriate airway clearance technique (ACT) for the individual patient. It is based on a 
synthesis of the physiological evidence that supports the modulation of ventilation and 
expiratory airflow as a means of assisting airway clearance. By possessing a strong 
understanding of the physiological basis for ACTs, it will enable clinicians to decide which 
ACT best aligns with the individual patient’s pathology in diseases with anatomical 
bronchiectasis and mucus hyper-secretion. 
The physiological underpinning of postural drainage is that by placing a patient in various 
positions, gravity enhances mobilisation of secretions. Newer ACTs are based on two other 
physiological premises: the ability to ventilate behind obstructed regions of the lung; and the 
capacity to achieve the minimum expiratory airflow bias necessary to mobilise secretions. 
After reviewing each ACT to determine if it utilises both ventilation and expiratory flow, 
these physiological concepts are assessed against the clinical evidence to provide a 
mechanism for the effectiveness of each ACT. This paper provides the clinical rationale 
necessary to determine the most appropriate ACT for each patient, thereby improving care. 
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Physiological Basis of Airway Clearance Techniques 
INTRODUCTION. Personalised medicine has been used to describe the application of 
genomics, proteomics and biomarkers to precisely tailor therapy according to various 
characteristics of an individual patient
.1
 This concept of personalised medicine can also be 
applied to a variety of therapies, such as airway clearance, by taking into account individual 
patients’ lung pathology, clinical, functional, environmental and social factors, as well as the 
physiological concepts underlying airway clearance techniques (ACTs). 
2
 Personalised 
medicine results in resources being more effectively directed to the most appropriate patients, 
thereby ensuring that patients receive the specific technique that optimises the likelihood of 
benefit in terms of lung health and time commitment. The use of ACT’s can be further 
enhanced by the appropriate use of inhaled medications such as mucoactive agents, however 
these medications are not within the scope of this review.
3
    
This paper provides an overview of the physiological principles underlying ACTs and links 
these physiological principles to the evidence base of commonly used ACTs. This will 
facilitate clinicians to personalise airway clearance techniques specific to patients underlying 
lung pathology as well as other clinical, functional, environmental and social factors. While 
some patients with chronic lung disease are ventilated, the vast majority are breathing 
spontaneously. As the physiological mechanisms described differ in ventilated patients, it 
must therefore be emphasised that this paper is written only for the spontaneously breathing 
patient.
4
  
Background 
ACTs are used to supplement the body’s mucociliary clearance system when it is impaired by 
disease. This system is an important lung defence mechanism consisting of: airway surface 
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liquid comprising of mucus and periciliary layers (PCL); ciliary epithelium; and, a cough 
mechanism.
5
 In healthy people, cilia beat at a mean frequency of between 11 - 13 Hz,
6
 
propelling mucus proximally up the airways at a rate of between 4 -5 mm/min.
7,8
 The rate of 
clearance is strongly influenced by the mucus’s hydration state, rigidity, and viscosity to 
elasticity ratio.
9,10
  
The mucociliary transport system is impaired in chronic suppurative lung diseases, such as 
cystic fibrosis (CF), primary ciliary dyskinesia (PCD) and bronchiectasis not caused by CF 
(BE). This is due to the occurrence of one or more of the following conditions: dehydration 
of the PCL; absence of lubricant activity which prevents adhesion of mucus to airway 
surfaces;
11
 an inherent defect within the cilia; or, immunodeficiencies including cellular 
defects. Any one of these may cause a failure of ciliary beat frequency and reduced 
mucociliary clearance. Once this mechanical defence system is breached, the lung is more 
susceptible to infection and inflammation that can result in further airway damage, eventually 
leading to bronchiectasis.
12 
  
To be effective, ACTs should assist the body’s natural mucociliary clearance system to 
transport secretions proximally up the airways. Historically, to achieve mucociliary 
clearance, postural drainage positions were utilized primarily for drainage by relying on 
gravity.
13
 However, there is little supporting evidence that postural drainage utilising gravity, 
effectively mobilises secretions.
14,15
 In CF patients, gravity in a head-down position increased 
the mucociliary clearance rate only from 0 mm/min to 3 – 5 mm/min
8
. Based on the 
assumption that mucociliary clearance rates in gravity dependant positions remain the same 
in different lung regions, to mobilise secretions from a sub-segmental airway in the lower 
lobe would require a patient to be placed in a head down position for approximately one hour. 
Thus, positioning a patient in a head-down position alone for 3- 5 minutes (as historically 
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used in CF centres), is expected to be ineffective and may even do harm by promoting gastro-
oesophageal reflux.
13,16-20
 Two studies, one in CF adults and the other in patients with chronic 
bronchitis using radiolabeled tracer gases demonstrated that in the side-lying position more 
secretions are mobilised from the dependent lung than from the non-dependent lung, which 
suggests that the impact of body position on ventilation plays a greater role than gravity in 
mobilising secretions.
21-23
 Since this data was published there has been limited translation of 
these findings into clinical practice, suggesting why perhaps that in many countries, 
positioning for drainage remains a key ACT. Positioning for ventilation will be discussed 
later in this paper. 
Newer ACTs rely on two over-riding physiological principles. First, a mechanism to allow air 
to move behind obstruction and ventilate the regions distally, and second, modulation of 
expiratory airflow in such a way as to propel secretions proximally up the airways. This paper 
describes the physiological theories and evidence underlying the use of individual ACTs in 
the non-ventilated spontaneously breathing patient.  
1. Principles for optimising ventilation to obstructed regions of the lung.  
 
In normal healthy individuals, during inspiration, airflow takes the path of least resistance, 
ventilating all areas of the lung, although there may be some asynchronous ventilation 
secondary to regional and stratified inhomogeneity.
24
 In patients with obstructed airways, 
secretions decrease the diameter of the airway and increase airway resistance, causing 
preferential ventilation of unobstructed regions and hypoventilation of obstructed regions.
24
 
Over time, air gradually moves behind the obstruction, but it is not expired, leading to 
dynamic hyperinflation of the obstructed lung unit. Several mechanisms used in ACTs 
optimise ventilation to obstructed lung units.  
Interdependence during deep inspiration 
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When tidal volume is increased during a deep inspiration, expanding alveoli exert a traction 
force on less well expanded alveoli which they surround, thereby assisting in the re-expansion 
of collapsed alveoli due to the elasticity of the surrounding interstitium. This is known as 
“interdependence”. It results in air moving into the small airways obstructed by secretions, a 
phenomenon that has been called Pendelluft
25
 and which results from the “interdependence”. 
The theory of interdependence was proposed by Mead and a physical model was created to test 
this hypothesis.
26
 The theory was later confirmed in clinical studies on anesthetised dogs.
27
  
Collateral ventilation (CV) 
Ventilation can also occur between adjacent lung segments through collateral channels.
28,29
 In 
healthy individuals, the importance of CV is negligible due to resistance to airflow being 
higher in the collateral channels than in the airways. However, if an airway proximal to these 
collaterals becomes blocked, the collateral channels allow air to move through these 
pathways due to the pressure differences between adjacent lung units and function to 
minimise collapse of lung units. Studies have shown that excised human lungs can be re-
inflated using collateral channels.
30,31
 There are three types of collateral connections: 
channels of Lambert; pores of Kohn; and, pathways/channels of Martin.      
 Channels of Lambert represent epithelium-lined tubular communications between distal 
bronchioles and the adjacent alveoli. These are most likely the primary channels responsible 
for CV.
32 
Pores of Kohn are inter-alveolar connections. There are approximately 50 pores of 
Kohn varying from 3 to 13µm in diameter in each alveolus.
33,34
 In vivo, these pores are 
mostly filled by fluid and act as a pathway for alveolar lining fluid, surfactant components, 
and cells like macrophages to move between adjacent alveoli.
34 
Lastly, there exist Pathways 
of Martin/channels of Martin, which are interbronchiolar connections. Results of an 
experiment with excised dogs lungs, pressurised to between 17 – 28 cms H2O, indicated 
connections between respiratory bronchioles and terminal bronchioles from adjacent lung 
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segments,
35
 suggesting that use of collateral ventilation channels forms the basis for use of 
positive expiratory pressure ACTs .                             
 
Three second breath hold 
A three second breath hold is another method of ventilating obstructed lung units. When the 
unobstructed region of the lung has been preferentially ventilated a pause for three seconds 
alters the time constants and allows air to move from the unobstructed regions, where the 
pressure gradient is higher, to the obstructed regions of the lung. This transient movement of 
gas out of some alveoli into another at the end of inspiration is known as Pendelluft flow. 
Multiple-breath washout tests have shown that a breath hold increases alveolar gas mixing 
and decreases the inhomogeneity of ventilation in normal subjects.
36
 In post-operative clinical 
practice it has been demonstrated that a three second breath hold is effective in reducing 
atelectasis.
37
 
Positioning to optimise ventilation in adults and children  
Positioning may be used to enhance ventilation to specific lung regions where secretions are 
located, such as in bronchiectasis patients. The increased ventilation to those lung regions can 
then be used effectively to mobilise secretions.
21,22
 There are differences in chest shape and 
lung mechanics between adults and children which result in differences in ventilation patterns.  
When adults are placed in the upright position, optimum ventilation occurs in the mid and 
lower lobes, while perfusion is greatest in the lower lobes. Theoretically, ventilation/perfusion 
ratio V/Q = 1 is at the level of the right middle lobe and lingula.
38
 When an adult is placed in 
side-lying, the dependent lung is preferentially ventilated due to the dependent hemi-diaphragm 
being stretched, causing a greater length to tension ratio, with increased contractility. This 
creates a greater negative pleural pressure, which clinically results in increased ventilation.
39
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Perfusion is greater to the dependent lung in both adults and children because it is gravity 
dependent. 
When very young children are placed in side-lying, the non-dependant lung is preferentially 
ventilated, most likely due to the differences in their lung and chest wall mechanics. This 
occurs in children up to age 12 years, causing airway closure to occur in the more dependent 
regions, independent of lung disease.
39
  
Supine is the best position to ventilate the upper lobes.
38
 However, if this is not suitable, as 
when taking an inhaled medication, side lying may be an alternative position. Inhaled drug 
deposition is improved by 13% to the dependent upper lobe when healthy adults were placed 
in side-lying. Adults with mild CF lung disease improve upper lobe deposition by 4% with 
the same side lying strategy
40
 Table 1 shows optimal positioning for use during airway 
clearance to optimise ventilation to obstructed regions of the lung, based on changes in 
ventilation patterns with positioning. 
 
Table 1. Optimal positioning for airway clearance techniques to enhance ventilation to 
obstructed regions of the lung 
 
 Optimal position Alternative, 2
nd
 choice,  
Position  
Secretions in upper 
lobes 
Supine Side Lying 
Secretions in  middle 
lobe  and  lingula 
Upright Side Lying or Supine 
Secretions in right lung Adults: place in right   side 
lying 
Children: place in left side 
lying 
 
Secretions in left lung Adults: place in left side 
lying 
Children: place in right side 
lying 
 
Secretions lower lobes Upright Side Lying 
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Use of mobilisation to increase ventilation 
Moving a patient into different positions affects ventilation in two different ways. First, a 
change in body position alters regional ventilation as noted above. Second, by increasing the 
mobility of a patient, oxygen demand increases, resulting in a corresponding increase in 
minute ventilation and lung volumes.
41
 The resultant increase in ventilation allows air to 
move into obstructed lung units by interdependence and collateral ventilation.   
2. Methods of utilising expiratory airflow to enhance secretion removal  
Increasing  the velocity of the expiratory airflow in such a way as to create high shearing 
forces at the airway walls, and high kinetic energy that enhance the cephalad movement of 
secretions is a second key mechanism to mobilise airway  secretions. 
Cough  
Coughing is a normal reflex defence mechanism used to clear excessive secretions down to 
the 7
th
 or 8
th
 generation of airways.
42
 During a typical cough, a deep inspiration is followed 
by closure of the glottis. High intra-thoracic pressures (up to 300 mmHg) builds up, resulting 
in a high explosive, turbulent expiratory flow rate that may exceed 500 L/min
43
 when the 
glottis is opened. During this time, dynamic compression of the airways occurs, resulting in 
an increase in velocity and kinetic energy which produces a shear force detaching mucus 
from the airway walls and enhancing the cephalic movement of mucus proximally up the 
airways. Distal to the regions where the airways are compressed, there may be a collapse of 
the airways, especially when airway instability is present.
43
 
Cough is an effective method of clearing secretions from the larger airways in healthy 
individuals. However, in chronic supperative lung disease, where narrowing and “floppy” 
airways may close prematurely, it can have detrimental effects if used inappropriately over an 
extended period as the primary method of clearing secretions. When repeated coughs are 
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used, bronchial wall instability may result due to recurrent compression of the airways, 
thereby reducing expiratory flow and limiting the effectiveness of the cough.
44
 Therefore, we 
recommend that ACTs be used as the primary method of mobilising secretions from the 
middle and small airways to the larger airways. Then one effective cough be used to clear 
secretions from the larger airways, thereby preserving the integrity of the larger airways.  
Huff / Forced expiratory manoeuvre  
 A forced expiration manoeuvre may also be described as a “Huff”. It accelerates the 
expiratory airflow, creating high linear velocities that shear mucus from the airway walls. 
Unlike a cough that is performed with a closed glottis, a huff is performed with an open 
glottis. The huff concept is based on the equal pressure point theory (EPP).
45
 At the EPP, 
dynamic compression of the airways occurs, creating an increase in the linear velocity of the 
expiratory airflow which propels secretions proximally. The site of the EPP is determined by 
the size of expiratory force, airway stability, and the elastic recoil. Initiating a forced 
expiration at a low lung volume shifts the EPP to the periphery, targeting secretions in the 
small airways. Similarly, initiating a forced expiration from a high lung volume will move the 
EPP centrally towards the thoracic aperture. This is sometimes referred to as a “Huff-
Cough”.
38
  
 Two-phase gas-liquid flow mechanism 
Mucus clearance can be modelled as a two-phase gas-liquid flow mechnism.
46 
This indicates 
that peak expiratory flow rate (PEFR) must exceed peak inspiratory flow rate (PIFR) by at 
least 10% for mucus to move proximally. The peak expiratory flow rate must also exceed 30 
– 60 L/min to overcome the adhesive strength by which the mucus is attached to the 
interface. Mucus factors affecting mucociliary clearance are the mucus depth and the 
viscoelastic properties of mucus. Viscosity is a liquid property of mucus, whereas elasticity is 
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described as the energy storage with an applied stress to a solid. The rate of mucus transport 
is higher with viscoelastic mucus than with non-elastic viscous mucus.
47
 
During normal tidal volume breathing at rest, PEFR does not exceed 30 L/min and PIFR is 
greater than PEFR. The result is that secretions are not mobilised. In order to use airflow to 
mobilise secretions it is necessary to optimise the expiratory airflow so that the PEFR > PIFR 
by at least 10%, and the velocity of the expiratory flow rate is at least 30 – 60 L/min, 
depending on the properties of the secretions. In a clinical study that examined the effect of a 
cough and a huff on regional lung clearance, PEFR recorded with a cough was 288 (29) l/min 
and 203 (25) l/min with a huff.
48
  Both were sufficient to increase tracheobronchial clearance 
by 44% and 42% respectively, confirming that an increase in PEFR will enhance lung 
clearance.
48
 Further studies have demonstrated that, in addition to huffing and coughing, 
manual vibration, oscillating positive expiratory pressure (using the Flutter VRP1) as well as 
autogenic drainage met the criteria for using expiratory flow to mobilise secretions 
proximally.
49,50
 (Table 2)   
Table 2. Effects of airway clearance interventions on peak expiratory flow rates. 
Intervention Subject n PEFR L/mins PIFR L/min PEFR/PIFR 
 Ratio 
Frequency 
Hz 
Huff 17 302.4±121.8 124.8±85.2 2.80  
Cough 17 280.2±114.6 100.8±44.4 3.07  
Vibration 
Autogenic 
Drainage 
17 
14 
    94.8±43.8 
    85.2±28.8 
  63.6±16.2 
  50.4±13.8 
1.51 
1.69 
  8.4±0.4 
 
Flutter 17     67.8±18.0   63.0±16.2 1.15 11.3±1.5 
Percussion 18      49.8±8.4   50.4±6.0 0.99   7.3±0.3 
Acapella 18      35.4±4.8  58.8±16.2 0.64 13.5±1.7 
PEP 
 
18 
 
     26.4±9.0 
 
57.6±12.0 
 
0.47 
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Data are represented as mean±SD of each subject. Table adapted from work by McCarren
49
 and McIlwaine’s 
own work.
50,51
 Peak expiratory Flow Rate (PEFR) and Peak Inspiratory Flow Rate are recorded in Litres per 
minute.  
Effects of expiratory airflow on airway surface liquid 
There have been studies on the effect of airflow on the volume of airway surface liquid 
(ASL), using an oscillatory motion device and a cyclic compressive device.
47,52
 The use of 
these devices caused normal airway cell cultures to double their ASL height with oscillatory 
motion of 0.3–0.4 Hz, and CF cultures to increase their ASL height to approximately 7µm, 
thereby being capable of maintaining mucus transport for protracted intervals. It is 
hypothesised that oscillatory shear stress stimulates Adenosine triphosphate (ATP), which in 
turn stimulates Ca
2+
 mediated Cl
-
 secretion and also inhibits the Na
+
 absorption. 
These important physiological findings provide some basis for the use of airway clearance 
techniques utilising expiratory airflow and pressure support. However, the oscillation rate of 
0.3 – 0.4 Hz, which is defined in these experiments, is only slightly greater than the rate of 
breathing in an adult, and does not equate to the oscillation rate of 11 – 15 Hz described 
below as the oscillation rate necessary for effective airway clearance. Further studies are 
needed to confirm these in vitro experiments. 
Oscillation  
Oscillation frequencies between 5 to 17 Hz improve tracheal mucus clearance rates in dogs 
with frequencies between 11 and 15 Hz increasing mucus clearance from 8.2 mm/min to 26 
mm/min,
53
 which corresponds with the ciliary beat frequency. Oscillations also have an effect 
on the mucus rheological properties of mucus rigidity (sum of viscosity and elasticity), 
spinnability (thread forming capacity of mucus), and a derived cough clearance index (CCI). 
A higher CCI indicates that the mucus is easier to clear with a cough. In an in vitro study, 
oscillations at 19 Hz using an oscillatory positive expiratory pressure device (Flutter VRP1) 
resulted in only a small non-significant decrease in mucus rigidity and no significant change 
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in the CCI.
54 
The use of rhDNase had the same effect. However, when oscillations were 
combined with rhDNase the result was a significant decrease in rigidity and a significant 
change in the CCI.  A 4 week clinical study confirmed the findings from the in vitro study 
and demonstrated a significant decrease in sputum rigidity and spinnability following 
oscillation with the Flutter compared to autogenic drainage.
55
 In another study of CF patients 
who exercised for 20 minutes on a treadmill, there was also a significant reduction in sputum 
rigidity.
56
 This result may be due to trunk oscillations associated with treadmill exercise. 
Vibrations  
Vibrations are the application of fine manual oscillatory movements (either back and forth or 
side to side) applied to the chest wall during expiration. In studies of healthy subjects 
vibrations increase peak expiratory flow rates (PEFR) by 50% over relaxed expiration.
57,58
 
The frequency of vibration and its effect on expiratory airflow has been compared to several 
other airway clearance interventions in clinical studies: Acapella; Positive Expiratory 
Pressure (PEP); Flutter; and, Percussion.
49
 Vibration was applied during expiration after a 
slow maximal inspiration (Table 2). The resultant PEFR of 1.58 L/s and PEFR/PIFR ratio of 
1.51, is sufficient to assist in mucus clearance and was greater than the other interventions, 
but lower than a huff or cough manoeuvre.
49
 This work has added greatly to our 
understanding of the effects of vibration, particularly its impact on expiratory flow rates. In 
addition, based on studies demonstrating that oscillation frequencies of between 5–17Hz 
improves mucocilliary clearance,
52 
 there is a sound rationale to suggest that vibrations with a 
frequency of <17 Hz will improve mucociliary transport.
49,58
 
3. Applying physiological principles to airway clearance techniques  
In order to determine which ACT is most suitable for the individual patient, it is important to 
understand how each ACT incorporates the physiological elements of ventilation and 
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expiratory airflow as described previously. Both are essential for enhancing mucus clearance. 
Table 3 gives a synopsis of the physiological basis for each ACT followed by a more detailed 
outline of their physiological components. The ACTs included in this section are those which 
are evidence based and have randomised controlled long-term clinical trials to support their 
use. There are other ACTs and ACT devices in use, which are currently being researched but 
have not been included in this review as they lack the rigour of long-term studies.   
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Table 3.  Physiological basis for each airway clearance technique.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Peak expiratory Flow Rate (PEFR) and Peak Inspiratory Flow Rate are recorded in Litres per minute.  
                                                          
1
 Each technique with the exception of AD incorporates huffing as used in FET. 
   
VENTILATION 
 
 
  
EXPIRATORY 
 
AIRFLOW 
 
 Interdependence 
 
Collateral  
Ventilation (CV) 
Breath hold Huffing1 PEFR/PIFR 
>1.1 
PEFR > 30 – 60  L/min Oscillation 
Active 
Cycle of 
Breathing 
Techniques 
Thoracic 
expansion 
exercises utilise 
interdependence 
Thoracic expansion 
exercises utilise CV 
Sometimes used 
with this technique 
if hypo- ventilating 
Uses forced 
expirations at 
different levels 
Ratio = 2.8 Average 302 L/min with 
huffing 
No 
Autogenic 
Drainage 
No Yes with breath hold Uses 3 second 
breath hold with 
each breath 
Only used to 
clear secretions 
from larger 
airways if 
needed  
Yes, emphasis  is 
on slow inspiration 
and increased 
velocity on 
expiration 
40 – 70 L/min. Depends 
on level of breathing and 
degree of airway 
obstruction 
No 
Positive 
Expiratory
Pressure 
No As PEP is maintained 
within the airways 
during 12 – 15 
breaths, use of CV is 
maximised. 
Not necessary as 
PEP is maintained 
within the airways 
during 12 – 15 
breaths.   
Used at end of 
each cycle of 12 
-15 breaths 
 
No 
Ratio = 0.47 
 
No 
Average 26 L/min 
No 
Oscillating 
Positive 
Expiratory 
Pressure with 
Flutter 
Oscillations 
between 3-5 Hz 
may play a role, 
but frequency 
used in Flutter is 
> 5 Hz  
Yes with breath hold Uses 3  second 
breath hold with 
each breath 
Used at end of 
each cycle of 8 -
10 breaths 
Ratio = 1.15  
Average 68 L/min 
2 - 32Hz 
Most often 
uses 6 - 26 
Hz 
Oscillating 
Positive 
Expiratory 
Pressure with 
Acapella 
Oscillations 
between 3-5 Hz 
may play a role, 
but frequency 
used in Acapella 
is > 5 Hz  
 As a PEP is 
maintained within the 
airways during 12 – 
15 breaths, use of CV 
is maximised  
Not necessary  Used at end of 
each cycle of 12 
-15 breaths 
No 
Ratio = 0.64 
Average 35.4 L/min 
Within PEFR range 
needed, but would 
depend, on viscoelastic 
and viscosity properties 
of secretions.  
 
10 - 18 Hz 
High 
FrequencyC
hestWallOsc
illation 
Oscillations 
between 3-5 Hz 
may play a role, 
but frequency 
used in HFCWO 
is > 5 Hz 
No No Interspersed 
with HFCWO 
Yes, expiratory 
flow rate is much 
higher than 
inspiratory flow 
rate. 
 
Average 120 L/min 
5-25 Hz 
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Active cycle of breathing techniques (ACBT)  
ACBT ventilates behind obstructed lung units, using interdependence and collateral ventilation, 
during thoracic expansion exercises.
59
 A three second breath hold is included at the end of 
inspiration. This increases alveolar gas mixing and decreases the inhomogeneity of ventilation.
36
 
(Table 3). The main driver of expiratory airflow is huffing, which relies on the use of EPP to 
enhance mucus clearance. The peak expiratory flow rate, with a huff at high lung volume, is 
similar to a cough (Table 2), demonstrating that the increase in air flow linear velocity is 
sufficient to promote cephalic movement of secretions.
60
 Both the breathing level at which the 
huff is performed and the strength of the huff are adjusted to allow the EPP to occur where the 
secretions are located. As huffing is a forced expiration manoeuvre which can lead to 
bronchospasm, it is necessary to intersperse it with breathing control i.e. the “Forced Expiration 
Technique (FET)” which is a combination of huffing and breathing control.
61
 ACBT is 
performed in either upright, recumbent positions or drainage positions.
60
 
Autogenic drainage (AD) 
In autogenic drainage (AD) ventilation to obstructed lung regions is achieved with a three second 
breath hold on inspiration during tidal volume breathing, utilising the collateral ventilation 
channels. The expiratory airflow is modulated so that at each level (unsticking phase, collecting 
phase, and evacuating phase), tidal volume breathing is performed and the expiratory airflow 
velocity is maximised without causing dynamic compression of the airways (Figure 1).
62,43 
In a 
study with patients who had obstructive lung disease, when AD was performed, the expiratory 
airflow varied between 40 – 70 L/min depending on lung volume and level of breathing, thereby 
moving secretions proximally.
50
 A slow inspiratory flow rate is necessary to create an expiratory 
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flow rate bias by at least 10%. AD is usually performed in an upright position, an alternate 
position may be used to enhance ventilation to specific lung regions.  
Positive Expiratory Pressure Mask 
Positive expiratory pressure, used in the PEP technique, is a flow regulating technique 
employing positive expiratory pressures between 10 – 20 cms of H2O.
 63,64
 FRC is temporarily 
increased by breathing through a closed system using a PEP Mask (Figure 2).
65
 Usually PEP is 
performed in a sitting position and the patient is instructed to take 12 – 15 tidal volume breaths 
through the PEP mask before it is removed for huffing.
66
  If the patient removes the mask 
prematurely, before completing 12 breaths, or uses a mouthpiece without a good seal, the 
positive pressure in the airways is lost and FRC returns to normal thereby lessening the effect of 
the technique. The effect of an application of PEP on collateral channels was demonstrated by 
Martin
35
.  The PEP technique uses a pressure similar to that used in studies on the effect of 
pressure on ASL.
47,52
 Therefore, it may also enhance mucociliary transport.  
While ventilation is improved through the use of the PEP mask, the expiratory airflow necessary 
to mobilise secretions proximally is not achieved as PEP only has a PEFR/PIFR of 0.47.
49
 PEP 
therefore needs to be combined with a manoeuvre such as huffing or autogenic drainage.  
Oscillating Positive Expiratory Pressure  
Flutter and Acapella devices generate an automatically controlled oscillating PEP, although both 
operate utilising different physiological bases. They provide similar frequency of oscillation 
within the range necessary to decrease the viscoelastic and spinnability properties of mucus, and 
thereby improve mucus clearance.
53,55
 Flutter oscillates with frequencies 6-26 Hz, with average 
PEP pressures of 18-35 cms H2O. Acapella oscillates with frequencies of 10 – 18 Hz, with an 
average pressure between 10 – 25 cms H2O.
67
 These oscillation frequencies are much higher than 
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the 0.3–0.4 Hz
47,52
 used in in-vitro experiments where ASL height was doubled. It has still to be 
determined what effect frequencies of 6- 26Hz have on ASL.  
 
Oscillating PEP with Flutter 
While exhaling through the flutter to ERV, the individual tunes the device to their ventilator 
abilities, thereby enabling a modulation of both pressure and airflow oscillation frequency 
increasing expiratory airflow to mobilise secretions proximally.
68
 Flutter produces an expiratory 
flow bias of PEFR/PIFR 1.15, which is sufficient to mobilise secretions.
49
 In addition, huffing is 
added at the end of each breathing cycle. Unlike the PEP Mask, FRC is not increased with the 
flutter due to the inability to inspire through the device. To overcome ventilatory asynchronism, 
inspiration is followed by a three second breath hold.  
While the Flutter meets the two criteria for mobilising secretions, it raises some concerns. 
Sometime, expiration is into the ERV where closing volume has the potential to cause airway 
closure.
69
 FRC level is not temporarily increased so that the effect of PEP on opening collateral 
channels is negated. However, the three second breath has been shown to increase alveolar gas 
mixing, alter time constants, and allow air to move distal to any obstruction. Another limitation 
of the Flutter is that due to its pipe-like design, it can only be used in the upright position. 
Oscillating PEP with Acapella 
Because inspiratory and expiratory manoeuvres are performed through the Acapella in a closed 
system for 12 to 15 breaths, its physiological basis is similar to the PEP technique, allowing air 
to move behind secretions through collateral ventilation channels as a result of an increased FRC 
level. The addition of oscillation should enhance the technique. Similar to PEP, the expiratory 
flow bias is insufficient with a PEFR/PIFR ratio of 0.64,
49
 therefore the Acapella needs to be 
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combined with huffing to assist in mucociliary clearance from the larger airways. Acapella is 
position independent, so it can be used in any position to optimise ventilation 
High frequency chest wall oscillation (HFCWO). 
During HFCWO (also known as High Frequency Chest Compression) oscillations are created 
over the chest wall at frequencies between 5–25 Hz. On expiration the oscillations enhance 
mucociliary transport in three essential ways, similar to the oscillations produced with oscillatory 
PEP devices: 1) by altering the rheological properties of mucus;
 54
 2) by creating an expiratory 
flow bias that shears mucus from the airway walls and encourages its movement proximally;
53
 
and, 3) by enhancing ciliary beat frequency.
70
 The oscillatory expiration flow generated by 
compression of the chest wall, (creating a PEFR up to 120 L/min), is sufficient to overcome 
mucus adhesion from the airway wall and propel it up the airway. However, the HFCWO device 
provides no means of ventilating behind obstructed airways.  Unlike the other oscillatory 
devices, HFCWO does not provide any PEP, and the end-expiratory volume has been reported to 
decrease 10-50% during compression.
71
 While this may improve expiratory flows through the 
smaller airways, it may worsen expiratory flows if the airways are smaller and airway resistance 
is increased, leading to early airway closure.
72
 This may lead to a worsening of lung disease.  
Several short-term randomised controlled trials in CF patients have been unable to demonstrate 
any significant difference between HFCWO and other ACTs.
73-76
 However, in two long term 
studies, HFCWO was associated with an increased number of respiratory exacerbations in one,
77
 
and by a decreased in lung function in the other.
78
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Personalising airway clearance strategies 
While no one ACT has been found to be more effective than another, as synthesised in five 
Cochrane reviews
79-83 
on ACT’s in CF, traditionally the choice of ACT has been based on: what 
is available locally; the training and expertise of the local physiotherapist; and culture.
84
 
However, a one size fits all approach based on regional preference may not address specific 
patient’s needs. An individualised strategy should take into account the patient’s disease state, 
preference, motivation, and maturity which, together with the physiological knowledge base of 
each ACT, apply the most effective airway clearance intervention for that individual.  Some 
examples of clinical considerations based on the unique physiological principles of each ACT 
are as follows: 
a) A deep inspiration with a three second breath hold is a particularly effective means of 
increasing ventilation in patients with a restrictive component to their lung disease
37
.  But 
using a 3 second breath hold in a patient with a severe lung disease who is tachypneaic 
may lead to hypoxia.  
b) A forced expiration, as used in ACBT and with the various PEP devices, needs to be 
adapted to the individual’s underlying lung pathology. In someone with collapsible 
airways, a huff may compress the airways in such a way as to limit expiratory airflow 
rather than to increase the velocity of airflow
43
. Alternatively, if bronchospasm is present, 
airflow obstruction is greater therefore one needs to reduce the force of the huff.  
c) In autogenic drainage the expiratory airflow is gently accelerated avoiding compression 
of the airways. This technique is therefore more favourably suited to patients with 
bronchospasm, or patients with haemoptysis, where a gentler technique is required. In a 
clinical study, patients with bronchospasm responded best to AD.
85
 As AD requires a 
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self-awareness of one’s own respiratory mechanics and concentration to perform, it is 
generally used in teenagers or adults, unless a caregiver is skilled in its performance.  
d) PEP increases FRC during tidal volume breathing, evening out intrapulmonary 
distribution of ventilation, opening up regions that are otherwise closed off.
65
 It is 
therefore effective in both restricted and obstructed patients. In addition, the positive 
expiratory pressure splints the airways during expiration thereby avoiding airway 
collapse, which makes it a favourable technique for patients with unstable airways. 
e) Adding oscillations to expiration, either by using a oscillatory PEP device or HFCWO 
device, has the added advantage of: increasing mucociliary clearance;
53
 decreasing the 
viscoelastic properties of mucus; and, potentially rehydrating mucus. When using 
oscillation devices, the clinician needs to consider what method they want to use to first 
ventilate behind the obstructed units. Flutter uses a three second breath hold, Acapella 
like PEP increases FRC, splinting airways open. HFCWO needs to be combined with 
either deep inspiratory manoeuvres, three second breath hold, or PEP.  
f) Exhaling into ERV, as used during AD, Flutter and HFCWO assists in mobilising 
secretions from the small airways but has the potential to cause airway closure.
62,69,71
 To 
avoid this, during these techniques, the therapist should ensure patients adequately 
incorporate methods to ventilate small airways such as three second breath holds, or 
thoracic expansion exercises. 
g) A therapeutic strategy for an individual patient may involve a combination of ACTs. For 
example, in a patient with unstable large airways, the use of a PEP device will enhance 
ventilation. But during the huffing phase the airways may be unable to resist 
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compression. By combining PEP with AD, expiratory flow rates could be increased 
without causing airway compression thereby mobilising secretions more effectively 
Conclusion  
The approach to care of the individual patient needs to be personalised. Sometimes, in clinical 
practice more than one ACT may be effective for a patient at a given time in their disease 
trajectory and choice of technique may then be dependent on availability and patient preference. 
Other considerations include cleaning and durability of an ACT device if one is used. However, 
more often than not, due to the varying nature of the underlying disease pathology; phenotypic 
characteristics; and, taking into account individual patients’ clinical, functional, environmental 
and social factors, ACTs needs to be personalised to meet patient’s specific needs. This requires 
a sound understanding of the physiological basis of each technique 
Examining the application of physiological principles to ACTs provides a better understanding 
of how to optimise airway clearance strategies to the individual patient’s underlying pathology. 
This allows for both more personalised and improved patient care. Physiological theories which 
support ACTs had previously been identified.
42,43,86 
 However, this is the first review to present 
the physiological evidence supporting methods to ventilate behind obstructed lung units, and 
modulation of expiratory airflow, and to collate this physiological evidence in an effort to assist 
in translation into practice. 
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Legends for figures 
Figure 1.  Breathing pattern during autogenic drainage 
Figure 2.  Schematic representation of breathing levels during PEP in an obstructed patient. Courtesy L. 
Lannefors 
 
Page 36 of 71
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
European Respiratory Review
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only - ERR
1 
 
Title page 
Title of article: Personalising airway clearance in chronic lung disease.  
 
Corresponding author:  
Maggie McIlwaine PhD, MCSP. 
Clinical Associate Professor 
University of British Columbia 
Professional Practice Leader, Physiotherapy 
Room K3-104 
BC Children's and Women's Hospital 
4480 Oak Street, 
Vancouver, BC, V6H 3V4 
Canada 
Email mmcilwaine@cw.bc.ca 
Phone 604 875 2123 
Fax 604 875 3220 
 
Co-authors: 
1. Prof Judy Bradley, PhD, BSc Hons Physiotherapy 
Position: - Director of Northern Ireland Clinical Research Facility  
Department: School of Medicine, Dentistry and Biomedical Sciences,  
Queens University Belfast,  
Belfast City Hospital, 51 Lisburn Road, 
Belfast, BT9 7AB 
N. Ireland.  
2. Prof J Stuart Elborn, MD, FRCP 
Position: Professor , Centre for Experimental Medicine Department: Queens University  
Whitla Medical Building Block  
97B MBC Site, Lisburn Road,  
Belfast, BT9 7BL 
N. Ireland  and   
National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, 
SW3 6LY. 
 
3. Dr Fidelma Moran, PhD, BSc Hons Physiotherapy, MCSP  
Position: Lecturer in Physiotherapy 
Department: Ulster University,  
Shore Road, Newtownabbey, BT 37 0QB  
N. Ireland. 
 
Page 37 of 71
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
European Respiratory Review
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only - ERR
2 
 
Key words: Airway clearance techniques, respiratory physiology, postural drainage,  
Word count : 3837 
 
ABSTRACT    
This review describes a framework for providing a personalised approach to selecting the 
most appropriate airway clearance technique (ACT) for the individual patient. It is based on a 
synthesis of the physiological evidence that supports the modulation of ventilation and 
expiratory airflow as a means of assisting airway clearance. By possessing a strong 
understanding of the physiological basis for ACTs, it will enable clinicians to decide which 
ACT best aligns with the individual patient’s pathology in diseases with anatomical 
bronchiectasis and mucus hyper-secretion. 
The physiological underpinning of postural drainage is that by placing a patient in various 
positions, gravity enhances mobilisation of secretions. Newer ACTs are based on two other 
physiological premises: the ability to ventilate behind obstructed regions of the lung; and the 
capacity to achieve the minimum expiratory airflow bias necessary to mobilise secretions. 
After reviewing each ACT to determine if it utilises both ventilation and expiratory flow, 
these physiological concepts are assessed against the clinical evidence to provide a 
mechanism for the effectiveness of each ACT. This paper provides the clinical rationale 
necessary to determine the most appropriate ACT for each patient, thereby improving care. 
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Physiological Basis of Airway Clearance Techniques 
INTRODUCTION. Personalised medicine has been used to describe the application of 
genomics, proteomics and biomarkers to precisely tailor therapy according to various 
characteristics of an individual patient
.1
 This concept of personalised medicine can also be 
applied to a variety of therapies, such as airway clearance, by taking into account individual 
patients’ lung pathology, clinical, functional, environmental and social factors, as well as the 
physiological concepts underlying airway clearance techniques (ACTs). 
2
 Personalised 
medicine results in resources being more effectively directed to the most appropriate patients, 
thereby ensuring that patients receive the specific technique that optimises the likelihood of 
benefit in terms of lung health and time commitment. The use of ACT’s can be further 
enhanced by the appropriate use of inhaled medications such as mucoactive agents, however 
these medications are not within the scope of this review.
3
    
This paper provides an overview of the physiological principles underlying ACTs and links 
these physiological principles to the evidence base of commonly used ACTs. This will 
facilitate clinicians to personalise airway clearance techniques specific to patients underlying 
lung pathology as well as other clinical, functional, environmental and social factors. While 
some patients with chronic lung disease are ventilated, the vast majority are breathing 
spontaneously. As the physiological mechanisms described differ in ventilated patients, it 
must therefore be emphasised that this paper is written only for the spontaneously breathing 
patient.
4
  
Background 
ACTs are used to supplement the body’s mucociliary clearance system when it is impaired by 
disease. This system is an important lung defence mechanism consisting of: airway surface 
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liquid comprising of mucus and periciliary layers (PCL); ciliary epithelium; and, a cough 
mechanism.
5
 In healthy people, cilia beat at a mean frequency of between 11 - 13 Hz,
6
 
propelling mucus proximally up the airways at a rate of between 4 -5 mm/min.
7,8
 The rate of 
clearance is strongly influenced by the mucus’s hydration state, rigidity, and viscosity to 
elasticity ratio.
9,10
  
The mucociliary transport system is impaired in chronic suppurative lung diseases, such as 
cystic fibrosis (CF), primary ciliary dyskinesia (PCD) and bronchiectasis not caused by CF 
(BE). This is due to the occurrence of one or more of the following conditions: dehydration 
of the PCL; absence of lubricant activity which prevents adhesion of mucus to airway 
surfaces;
11
 an inherent defect within the cilia; or, immunodeficiencies including cellular 
defects. Any one of these may cause a failure of ciliary beat frequency and reduced 
mucociliary clearance. Once this mechanical defence system is breached, the lung is more 
susceptible to infection and inflammation that can result in further airway damage, eventually 
leading to bronchiectasis.
12 
  
To be effective, ACTs should assist the body’s natural mucociliary clearance system to 
transport secretions proximally up the airways. Historically, to achieve mucociliary 
clearance, postural drainage positions were utilized primarily for drainage by relying on 
gravity.
13
 However, there is little supporting evidence that postural drainage utilising gravity, 
effectively mobilises secretions.
14,15
 In CF patients, gravity in a head-down position increased 
the mucociliary clearance rate only from 0 mm/min to 3 – 5 mm/min
8
. Based on the 
assumption that mucociliary clearance rates in gravity dependant positions remain the same 
in different lung regions, to mobilise secretions from a sub-segmental airway in the lower 
lobe would require a patient to be placed in a head down position for approximately one hour. 
Thus, positioning a patient in a head-down position alone for 3- 5 minutes (as historically 
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used in CF centres), is expected to be ineffective and may even do harm by promoting gastro-
oesophageal reflux.
13,16-20
 Two studies, one in CF adults and the other in patients with chronic 
bronchitis using radiolabeled tracer gases demonstrated that in the side-lying position more 
secretions are mobilised from the dependent lung than from the non-dependent lung, which 
suggests that the impact of body position on ventilation plays a greater role than gravity in 
mobilising secretions.
21-23
 Since this data was published there has been limited translation of 
these findings into clinical practice, suggesting why perhaps that in many countries, 
positioning for drainage remains a key ACT. Positioning for ventilation will be discussed 
later in this paper. 
Newer ACTs rely on two over-riding physiological principles. First, a mechanism to allow air 
to move behind obstruction and ventilate the regions distally, and second, modulation of 
expiratory airflow in such a way as to propel secretions proximally up the airways. This paper 
describes the physiological theories and evidence underlying the use of individual ACTs in 
the non-ventilated spontaneously breathing patient.  
1. Principles for optimising ventilation to obstructed regions of the lung.  
 
In normal healthy individuals, dDuring inspiration, airflow takes the path of least resistance, 
ventilating all areas of the lung, although there may be some asynchronous ventilation 
secondary to regional and stratified inhomogeneity.
24
 In patients with obstructed airways, 
sSecretions decrease the diameter of the airway and increase airway resistance, causing 
preferential ventilation of unobstructed regions and hypoventilation of obstructed regions.
24
 
Over time, air gradually moves behind the obstruction due to altered time constants, but it is 
not expired, leading to dynamic hyperinflation of the obstructed lung unit. Several 
mechanisms used in ACTs optimise ventilation to obstructed lung units.  
Interdependence during deep inspiration 
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When tidal volume is increased during a deep inspiration, expanding alveoli exert a traction 
force on less well expanded alveoli which they surround, thereby assisting in the re-expansion 
of collapsed alveoli due to the elasticity of the surrounding interstitium. This is known as 
“interdependence”. It results in air moving into the small airways obstructed by secretions, a 
phenomenon that has been called Pendelluft
25
 and which results from the “interdependence”. 
The theory of interdependence was proposed by Mead and a physical model was created to test 
this hypothesis.
26
 The theory was later confirmed in clinical studies on anesthetised dogs.
27
  
Collateral ventilation (CV) 
Ventilation can also occur between adjacent lung segments through collateral channels.
28,29
 In 
healthy individuals, the importance of CV is negligible due to resistance to airflow being 
higher in the collateral channels than in the airways. However, if an airway proximal to these 
collaterals becomes blocked, the collateral channels allow air to move through these 
pathways due to the pressure differences between adjacent lung units and function to 
minimise collapse of lung units. Studies have shown that excised human lungs can be re-
inflated using collateral channels.
30,31
 There are three types of collateral connections: 
channels of Lambert; pores of Kohn; and, pathways/channels of Martin.      
 Channels of Lambert represent epithelium-lined tubular communications between distal 
bronchioles and the adjacent alveoli. These are most likely the primary channels responsible 
for CV.
32 
Pores of Kohn are inter-alveolar connections. There are approximately 50 pores of 
Kohn varying from 3 to 13µm in diameter in each alveolus.
33,34
 In vivo, these pores are 
mostly filled by fluid and act as a pathway for alveolar lining fluid, surfactant components, 
and cells like macrophages to move between adjacent alveoli.
34 
Lastly, there exists Pathways 
of Martin/channels of Martin, which are interbronchiolar connections. Results of an 
experiment with excised dogs lungs, pressurised to between 17 – 28 cms H2O, indicated 
connections between respiratory bronchioles and terminal bronchioles from adjacent lung 
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segments,
35
 suggesting that use of collateral ventilation channels forms the basis for use of 
positive expiratory pressure ACTs .                             
 
Three second breath hold 
A three second breath hold is another method of ventilating obstructed lung units. When the 
unobstructed region of the lung has been preferentially ventilated a pause for three seconds 
alters the time constants and allows air to move from the unobstructed regions, where the 
pressure gradient is higher, to the obstructed regions of the lung. This transient movement of 
gas out of some alveoli into another at the end of inspiration is known as Pendelluft flow. 
Multiple-breath washout tests have shown that a breath hold increases alveolar gas mixing 
and decreases the inhomogeneity of ventilation in normal subjects.
36
 In post-operative clinical 
practice it has been demonstrated that a three second breath hold is effective in reducing 
atelectasis.
37
 
Positioning to optimise ventilation in adults and children  
Positioning may be used to enhance ventilation to specific lung regions where secretions are 
located, such as in bronchiectasis patients. The increased ventilation to those lung regions can 
then be used effectively to mobilise secretions.
21,22
 There are differences in chest shape and 
lung mechanics between adults and children which result in differences in ventilation patterns.  
When adults are placed in the upright position, optimum ventilation occurs in the mid and 
lower lobes, while perfusion is greatest in the lower lobes. Theoretically, ventilation/perfusion 
ratio V/Q = 1 is at the level of the right middle lobe and lingula.
38
 When an adult is placed in 
side-lying, the dependent lung is preferentially ventilated due to the dependent hemi-diaphragm 
being stretched, causing a greater length to tension ratio, with increased contractility. This 
creates a greater negative pleural pressure, which clinically results in increased ventilation.
39
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Perfusion is greater to the dependent lung in both adults and children because it is gravity 
dependent. 
When very young children are placed in side-lying, the non-dependant lung is preferentially 
ventilated, most likely due to the differences in their lung and chest wall mechanics. This 
occurs in children up to age 12 years, causing airway closure to occur in the more dependent 
regions, independent of lung disease.
39
  
Supine is the best position to ventilate the upper lobes.
38
 However, if this is not suitable, as 
when taking an inhaled medication, side lying may be an alternative position. Inhaled drug 
deposition is improved by 13% to the dependent upper lobe when healthy adults were placed 
in side-lying. Adults with mild CF lung disease improve upper lobe deposition by 4% with 
the same side lying strategy
40
 Table 1 shows optimal positioning for use during airway 
clearance to optimise ventilation to obstructed regions of the lung, based on changes in 
ventilation patterns with positioning. 
 
Table 1. Optimal positioning for airway clearance techniques to enhance ventilation to 
obstructed regions of the lung 
 
 Optimal position Alternative, 2
nd
 choice,  
Position  
Secretions in upper 
lobes 
Supine Side Lying 
Secretions in  middle 
lobe  and  lingula 
Upright Side Lying or Supine 
Secretions in right lung Adults: place in right   side 
lying 
Children: place in left side 
lying 
 
Secretions in left lung Adults: place in left side 
lying 
Children: place in right side 
lying 
 
Secretions lower lobes Upright Side Lying 
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Use of mobilisation to increase ventilation 
Moving a patient into different positions affects ventilation in two different ways. First, a 
change in body position alters regional ventilation as noted above. Second, by increasing the 
mobility of a patient, oxygen demand increases, resulting in a corresponding increase in 
minute ventilation and lung volumes.
41
 The resultant increase in ventilation allows air to 
move into obstructed lung units by interdependence and collateral ventilation.   
2. Methods of utilising expiratory airflow to enhance secretion removal  
Increasing  the velocity of the expiratory airflow in such a way as to create high shearing 
forces at the airway walls, and high kinetic energy that enhance the cephalad movement of 
secretions is a second key mechanism to mobilise airway  secretions. 
Cough  
Coughing is a normal reflex defence mechanism used to clear excessive secretions down to 
the 7
th
 or 8
th
 generation of airways.
42
 During a typical cough, a deep inspiration is followed 
by closure of the glottis. High intra-thoracic pressures (up to 300 mmHg) builds up, resulting 
in a high explosive, turbulent expiratory flow rate that may exceed 500 L/min
43
 when the 
glottis is opened. During this time, dynamic compression of the airways occurs, resulting in 
an increase in velocity and kinetic energy which produces a shear force detaching mucus 
from the airway walls and enhancinges the cephalic movement of mucus proximally up the 
airways., and overcomes the shear force of mucus attached to the airway walls. Distal to the 
regions where the airways are compressed, there may be a collapse of the airways, especially 
when airway instability is present.
43
 
Cough is an effective method of clearing secretions from the larger airways in healthy 
individuals. However, in chronic supperative lung disease, where narrowing and “floppy” 
airways may close prematurely, it can have detrimental effects if used inappropriately over an 
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extended period as the primary method of clearing secretions. When repeated coughs are 
used, bronchial wall instability may result due to recurrent compression of the airways, 
thereby reducing expiratory flow and limiting the effectiveness of the cough.
44
 Therefore, we 
recommend that ACTs be used as the primary method of mobilising secretions from the 
middle and small airways to the larger airways. Then one effective cough be used to clear 
secretions from the larger airways, thereby preserving the integrity of the larger airways.  
Huff / Forced expiratory manoeuvre  
 A forced expiration manoeuvre may also be described as a “Huff”. It accelerates the 
expiratory airflow, creating high linear velocities that shear mucus from the airway walls. 
Unlike a cough that is performed with a closed glottis, a huff is performed with an open 
glottis. The huff concept is based on the equal pressure point theory (EPP).
45
 At the EPP, 
dynamic compression of the airways occurs, creating an increase in the linear velocity of the 
expiratory airflow which propels secretions proximally. The site of the EPP is determined by 
the size of expiratory force, airway stability, and the elastic recoil. Initiating a forced 
expiration at a low lung volume shifts the EPP to the periphery, targeting secretions in the 
small airways. Similarly, initiating a forced expiration from a high lung volume will move the 
EPP centrally towards the thoracic aperture. This is sometimes referred to as a “Huff-
Cough”.
38
  
 Two-phase gas-liquid flow mechanism 
Mucus clearance can be modelled as a two-phase gas-liquid flow mechnism.
46 
This indicates 
that peak expiratory flow rate (PEFR) must exceed peak inspiratory flow rate (PIFR) by at 
least 10% for mucus to move proximally. The peak expiratory flow rate must also exceed 30 
– 60 L/min to overcome the adhesive strengthshear force by which the mucus is attached to 
the interface. Mucus factors affecting mucociliary clearance are the mucus depth and the 
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viscoelastic properties of mucus. Viscosity is a liquid property of mucus, whereas elasticity is 
described as the energy storage with an applied stress to a solid. The rate of mucus transport 
is higher with viscoelastic mucus than with non-elastic viscous mucus.
47
 
During normal tidal volume breathing at rest, PEFR does not exceed 30 L/min and PIFR is 
greater than PEFR. The result is that secretions are not mobilised. In order to use airflow to 
mobilise secretions it is necessary to optimise the expiratory airflow so that the PEFR > PIFR 
by at least 10%, and the velocity of the expiratory flow rate is at least 30 – 60 L/min, 
depending on the properties of the secretions. In a clinical study that examined the effect of a 
cough and a huff on regional lung clearance, PEFR recorded with a cough was 288 (29) l/min 
and 203 (25) l/min with a huff.
48
  Both were sufficient to increase tracheobronchial clearance 
by 44% and 42% respectively, confirming that an increase in PEFR will enhance lung 
clearance.
48
 Further studies have demonstrated that, in addition to huffing and coughing, 
manual vibration, oscillating positive expiratory pressure (using the Flutter VRP1) as well as 
autogenic drainage met the criteria for using expiratory flow to mobilise secretions 
proximally.
49,50
 (Table 2)   
Table 2. Effects of airway clearance interventions on peak expiratory flow rates. 
Intervention Subject n PEFR L/mins PIFR L/min PEFR/PIFR 
 Ratio 
Frequency 
Hz 
Huff 17 302.4±121.8 124.8±85.2 2.80  
Cough 17 280.2±114.6 100.8±44.4 3.07  
Vibration 
Autogenic 
Drainage 
17 
14 
    94.8±43.8 
    85.2±28.8 
  63.6±16.2 
  50.4±13.8 
1.51 
1.69 
  8.4±0.4 
 
Flutter 17     67.8±18.0   63.0±16.2 1.15 11.3±1.5 
Percussion 18      49.8±8.4   50.4±6.0 0.99   7.3±0.3 
Acapella 18      35.4±4.8  58.8±16.2 0.64 13.5±1.7 
PEP 18      26.4±9.0 57.6±12.0 0.47  
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Data are represented as mean±SD of each subject. Table adapted from work by McCarren
49
 and McIlwaine’s 
own work.
50,51
 Peak expiratory Flow Rate (PEFR) and Peak Inspiratory Flow Rate are recorded in Litres per 
minute.  
Effects of expiratory airflow on airway surface liquid 
There have been studies on the effect of airflow on the volume of airway surface liquid 
(ASL), using an oscillatory motion device and a cyclic compressive device.
47,52
 The use of 
these devices caused normal airway cell cultures to double their ASL height with oscillatory 
motion of 0.3–0.4 Hz, and CF cultures to increase their ASL height to approximately 7µm, 
thereby being capable of maintaining mucus transport for protracted intervals. It is 
hypothesised that oscillatory shear stress stimulates Adenosine triphosphate (ATP), which in 
turn stimulates Ca
2+
 mediated Cl
-
 secretion and also inhibits the Na
+
 absorption. 
These important physiological findings provide some basis for the use of airway clearance 
techniques utilising expiratory airflow and pressure support. However, the oscillation rate of 
0.3 – 0.4 Hz, which is defined in these experiments, is only slightly greater than the rate of 
breathing in an adult, and does not equate to the oscillation rate of 11 – 15 Hz described 
below as the oscillation rate necessary for effective airway clearance. Further studies are 
needed to confirm these in vitro experiments. 
Oscillation  
Oscillation frequencies between 5 to 17 Hz improve tracheal mucus clearance rates in dogs 
with frequencies between 11 and 15 Hz increasing mucus clearance from 8.2 mm/min to 26 
mm/min,
53
 which corresponds with the ciliary beat frequency. Oscillations also have an effect 
on the mucus rheological properties of mucus rigidity (sum of viscosity and elasticity), 
spinnability (thread forming capacity of mucus), and a derived cough clearance index (CCI). 
A higher CCI indicates that the mucus is easier to clear with a cough. In an in vitro study, 
oscillations at 19 Hz using an oscillatory positive expiratory pressure device (Flutter VRP1) 
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resulted in only a small non-significant decrease in mucus rigidity and no significant change 
in the CCI.
54 
The use of rhDNase had the same effect. However, when oscillations were 
combined with rhDNase the result was a significant decrease in rigidity and a significant 
change in the CCI.  A 4 week clinical study confirmed the findings from the in vitro study 
and demonstrated a significant decrease in sputum rigidity and spinnability following 
oscillation with the Flutter compared to autogenic drainage.
55
 In another study of CF patients 
who exercised for 20 minutes on a treadmill, there was also a significant reduction in sputum 
rigidity.
56
 This result may be due to trunk oscillations associated with treadmill exercise. 
Vibrations  
Vibrations are the application of fine manual oscillatory movements (either back and forth or 
side to side) applied to the chest wall during expiration. In studies of healthy subjects 
vibrations increase peak expiratory flow rates (PEFR) by 50% over relaxed expiration.
57,58
 
The frequency of vibration and its effect on expiratory airflow has been compared to several 
other airway clearance interventions in clinical studies: Acapella; Positive Expiratory 
Pressure (PEP); Flutter; and, Percussion.
49
 Vibration was applied during expiration after a 
slow maximal inspiration (Table 2). The resultant PEFR of 1.58 L/s and PEFR/PIFR ratio of 
1.51, is sufficient to assist in mucus clearance and was greater than the other interventions, 
but lower than a huff or cough manoeuvre.
49
 This work has added greatly to our 
understanding of the effects of vibration, particularly its impact on expiratory flow rates. In 
addition, based on studies demonstrating that oscillation frequencies of between 5–17Hz 
improves mucocilliary clearance,
52 
 there is a sound rationale to suggest that vibrations with a 
frequency of <17 Hz will improve mucociliary transport.
49,58
 
3. Applying physiological principles to airway clearance techniques  
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In order to determine which ACT is most suitable for the individual patient, it is important to 
understand how each ACT incorporates the physiological elements of ventilation and 
expiratory airflow as described previously. Both are essential for enhancing mucus clearance. 
Table 3 gives a synopsis of the physiological basis for each ACT followed by a more detailed 
outline of their physiological components. The ACTs included in this section are those which 
are evidence based and have randomised controlled long-term clinical trials to support their 
use. There are other ACTs and ACT devices in use, which are currently being researched but 
have not been included in this review as they lack the rigour of long-term studies.   
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Table 3.  Physiological basis for each airway clearance technique.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Peak expiratory Flow Rate (PEFR) and Peak Inspiratory Flow Rate are recorded in Litres per minute.  
                                                          
1
 Each technique with the exception of AD incorporates huffing as used in FET. 
   
VENTILATION 
 
 
  
EXPIRATORY 
 
AIRFLOW 
 
 Interdependence 
 
Collateral  
Ventilation (CV) 
Breath hold Huffing1 PEFR/PIFR 
>1.1 
PEFR > 30 – 60  L/min Oscillation 
Active 
Cycle of 
Breathing 
Techniques 
Thoracic 
expansion 
exercises utilise 
interdependence 
Thoracic expansion 
exercises utilise CV 
Sometimes used 
with this technique 
if hypo- ventilating 
Uses forced 
expirations at 
different levels 
Ratio = 2.8 Average 302 L/min with 
huffing 
No 
Autogenic 
Drainage 
No Yes with breath hold Uses 3 second 
breath hold with 
each breath 
Only used to 
clear secretions 
from larger 
airways if 
needed  
Yes, emphasis  is 
on slow inspiration 
and increased 
velocity on 
expiration 
40 – 70 L/min. Depends 
on level of breathing and 
degree of airway 
obstruction 
No 
Positive 
Expiratory
Pressure 
No As PEP is maintained 
within the airways 
during 12 – 15 
breaths, use of CV is 
maximised. 
Not necessary as 
PEP is maintained 
within the airways 
during 12 – 15 
breaths.   
Used at end of 
each cycle of 12 
-15 breaths 
 
No 
Ratio = 0.47 
 
No 
Average 26 L/min 
No 
Oscillating 
Positive 
Expiratory 
Pressure with 
Flutter 
Oscillations 
between 3-5 Hz 
may play a role, 
but frequency 
used in Flutter is 
> 5 Hz  
Yes with breath hold Uses 3  second 
breath hold with 
each breath 
Used at end of 
each cycle of 8 -
10 breaths 
Ratio = 1.15  
Average 68 L/min 
2 - 32Hz 
Most often 
uses 6 - 26 
Hz 
Oscillating 
Positive 
Expiratory 
Pressure with 
Acapella 
Oscillations 
between 3-5 Hz 
may play a role, 
but frequency 
used in Acapella 
is > 5 Hz  
 As a PEP is 
maintained within the 
airways during 12 – 
15 breaths, use of CV 
is maximised  
Not necessary  Used at end of 
each cycle of 12 
-15 breaths 
No 
Ratio = 0.64 
Average 35.4 L/min 
Within PEFR range 
needed, but would 
depend, on viscoelastic 
and viscosity properties 
of secretions.  
 
10 - 18 Hz 
High 
FrequencyC
hestWallOsc
illation 
Oscillations 
between 3-5 Hz 
may play a role, 
but frequency 
used in HFCWO 
is > 5 Hz 
No No Interspersed 
with HFCWO 
Yes, expiratory 
flow rate is much 
higher than 
inspiratory flow 
rate. 
 
Average 120 L/min 
5-25 Hz 
Page 51 of 71
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
European Respiratory Review
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only - ERR
16 
 
Active cycle of breathing techniques (ACBT)  
ACBT ventilates behind obstructed lung units, using interdependence and collateral ventilation, 
during thoracic expansion exercises.
59
 When Aa three second breath hold is included at the end 
of inspiration. This , increases alveolar gas mixing and decreases the inhomogeneity of 
ventilationtime constants are further altered thereby allowing more time for the pressure gradient 
to equalise in the obstructed units.
36
 (Table 3). The main driver of expiratory airflow is huffing, 
which relies on the use of EPP to enhance mucus clearance. The peak expiratory flow rate, with 
a huff at high lung volume, is similar to a cough (Table 2), demonstrating that the increase in air 
flow linear velocity is sufficient to promote cephalic movement of secretions.
60
 Both the 
breathing level at which the huff is performed and the strength of the huff are adjusted to allow 
the EPP to occur where the secretions are located. As huffing is a forced expiration manoeuvre 
which can lead to bronchospasm, it is necessary to intersperse it with breathing control i.e. the 
“Forced Expiration Technique (FET)” which is a combination of huffing and breathing control.
61
 
ACBT is performed in either upright, recumbent positions or drainage positions.
60
 
Autogenic drainage (AD) 
In autogenic drainage (AD) ventilation to obstructed lung regions is achieved with a three second 
breath hold on inspiration during tidal volume breathing, utilising the collateral ventilation 
channels. The expiratory airflow is modulated so that at each level (unsticking phase, collecting 
phase, and evacuating phase), tidal volume breathing is performed and the expiratory airflow 
velocity is maximised without causing dynamic compression of the airways (Figure 1).
62,43 
In a 
study with patients who had obstructive lung disease, when AD was performed, the expiratory 
airflow varied between 40 – 70 L/min depending on lung volume and level of breathing, thereby 
moving secretions proximally.
50
 A slow inspiratory flow rate is necessary to create an expiratory 
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flow rate bias by at least 10%. AD is usually performed in an upright position, an alternate 
position may be used to enhance ventilation to specific lung regions.  
Positive Expiratory Pressure Mask 
Positive expiratory pressure, used in the PEP technique, is a flow regulating technique 
employing positive expiratory pressures between 10 – 20 cms of H2O.
 63,64
 FRC is temporarily 
increased by breathing through a closed system using a PEP Mask (Figure 2).
65
 Usually PEP is 
performed in a sitting position and the patient is instructed to take 12 – 15 tidal volume breaths 
through the PEP mask before it is removed for huffing.
66
  If the patient removes the mask 
prematurely, before completing 12 breaths, or uses a mouthpiece without a good seal, the 
positive pressure in the airways is lost and FRC returns to normal thereby lessening the effect of 
the technique. The effect of an application of PEP on collateral channels was demonstrated by 
Martin
35
.  The PEP technique uses a pressure similar to that used in studies on the effect of 
pressure on ASL.
47,52
 Therefore, it may also enhance mucociliary transport.  
While ventilation is improved through the use of the PEP mask, the expiratory airflow necessary 
to mobilise secretions proximally is not achieved as PEP only has a PEFR/PIFR of 0.47.
49
 PEP 
therefore needs to be combined with a manoeuvre such as huffing or autogenic drainage.  
Oscillating Positive Expiratory Pressure  
Flutter and Acapella devices generate an automatically controlled oscillating PEP, although both 
operate utilising different physiological bases. They provide similar frequency of oscillation 
within the range necessary to decrease the viscoelastic and spinnability properties of mucus, and 
thereby improve mucus clearance.
53,55
 Flutter oscillates with frequencies 6-26 Hz, with average 
PEP pressures of 18-35 cms H2O. Acapella oscillates with frequencies of 10 – 18 Hz, with an 
average pressure between 10 – 25 cms H2O.
67
 These oscillation frequencies are much higher than 
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the 0.3–0.4 Hz
47,52
 used in in-vitro experiments where ASL height was doubled. It has still to be 
determined what effect frequencies of 6- 26Hz have on ASL.  
 
Oscillating PEP with Flutter 
While exhaling through the flutter to ERV, the individual tunes the device to their ventilator 
abilities, thereby enabling a modulation of both pressure and airflow oscillation frequency 
increasing expiratory airflow to mobilise secretions proximally.
68
 Flutter produces an expiratory 
flow bias of PEFR/PIFR 1.15, which is sufficient to mobilise secretions.
49
 In addition, huffing is 
added at the end of each breathing cycle. Unlike the PEP Mask, FRC is not increased with the 
flutter due to the inability to inspire through the device. To overcome ventilatory asynchronism, 
inspiration is followed by a three second breath hold.  
While the Flutter meets the two criteria for mobilising secretions, it raises some concerns. 
Sometime, expiration is into the ERV where closing volume has the potential to cause airway 
closure.
69
 FRC level is not temporarily increased so that the effect of PEP on opening collateral 
channels is negated. However, the three second breath has been shown to increase alveolar gas 
mixing, alter time constants, and allow air to move distal to any obstruction. Another limitation 
of the Flutter is that due to its pipe-like design, it can only be used in the upright position. 
Oscillating PEP with Acapella 
Because inspiratory and expiratory manoeuvres are performed through the Acapella in a closed 
system for 12 to 15 breaths, its physiological basis is similar to the PEP technique, allowing air 
to move behind secretions through collateral ventilation channels as a result of an increased FRC 
level. The addition of oscillation should enhance the technique. Similar to PEP, the expiratory 
flow bias is insufficient with a PEFR/PIFR ratio of 0.64,
49
 therefore the Acapella needs to be 
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combined with huffing to assist in mucociliary clearance from the larger airways. Acapella is 
position independent, so it can be used in any position to optimise ventilation 
High frequency chest wall oscillation (HFCWO). 
During HFCWO (also known as High Frequency Chest Compression) oscillations are created 
over the chest wall at frequencies between 5–25 Hz. On expiration the oscillations enhance 
mucociliary transport in three essential ways, similar to the oscillations produced with oscillatory 
PEP devices: 1) by altering the rheological properties of mucus;
 54
 2) by creating an expiratory 
flow bias that shears mucus from the airway walls and encourages its movement proximally;
53
 
and, 3) by enhancing ciliary beat frequency.
70
 The oscillatory expiration flow generated by 
compression of the chest wall, (creating a PEFR up to 120 L/min), is sufficient to overcome 
mucus adhesion from the airway wall and propel it up the airway. However, the HFCWO device 
provides no means of ventilating behind obstructed airways.  Unlike the other oscillatory 
devices, HFCWO does not provide any PEP, and the end-expiratory volume has been reported to 
decrease 10-50% during compression.
71
 While this may improve expiratory flows through the 
smaller airways, it may worsen expiratory flows if the airways are smaller and airway resistance 
is increased, leading to early airway closure.
72
 This may lead to a worsening of lung disease.  
Several short-term randomised controlled trials in CF patients have been unable to demonstrate 
any significant difference between HFCWO and other ACTs.
73-76
 However, in two long term 
studies, HFCWO was associated with an increased number of respiratory exacerbations in one,
77
 
and by a decreased in lung function in the other.
78
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Personalising airway clearance strategies 
While no one ACT has been found to be more effective than another, as synthesised in five 
Cochrane reviews
79-83 
on ACT’s in CF, traditionally the choice of ACT has been based on: what 
is available locally; the training and expertise of the local physiotherapist; and culture.
84
 
However, a one size fits all approach based on regional preference may not address specific 
patient’s needs. An individualised strategy should take into account the patient’s disease state, 
preference, motivation, and maturity which, together with the physiological knowledge base of 
each ACT, apply the most effective airway clearance intervention for that individual.  Some 
examples of clinical considerations based on the unique physiological principles of each ACT 
are as follows: 
a) A deep inspiration with a three second breath hold is a particularly effective means of 
increasing ventilation in patients with a restrictive component to their lung disease
37
.  But 
using a 3 second breath hold in a patient with a severe lung disease who is tachypneaic 
may lead to hypoxia.  
b) A forced expiration, as used in ACBT and with the various PEP devices, needs to be 
adapted to the individual’s underlying lung pathology. In someone with collapsible 
airways, a huff may compress the airways in such a way as to limit expiratory airflow 
rather than to increase the velocity of airflow
43
. Alternatively, if bronchospasm is present, 
airflow obstruction is greater therefore one needs to reduce the force of the huff.  
c) In autogenic drainage the expiratory airflow is gently accelerated avoiding compression 
of the airways. This technique is therefore more favourably suited to patients with 
bronchospasm, or patients with haemoptysis, where a gentler technique is required. In a 
clinical study, patients with bronchospasm responded best to AD.
85
 As AD requires a 
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self-awareness of one’s own respiratory mechanics and concentration to perform, it is 
generally used in teenagers or adults, unless a caregiver is skilled in its performance.  
d) PEP increases FRC during tidal volume breathing, evening out intrapulmonary 
distribution of ventilation, opening up regions that are otherwise closed off.
65
 It is 
therefore effective in both restricted and obstructed patients. In addition, the positive 
expiratory pressure splints the airways during expiration thereby avoiding airway 
collapse, which makes it a favourable technique for patients with unstable airways. 
e) Adding oscillations to expiration, either by using a oscillatory PEP device or HFCWO 
device, has the added advantage of: increasing mucociliary clearance;
53
 decreasing the 
viscoelastic properties of mucus; and, potentially rehydrating mucus. When using 
oscillation devices, the clinician needs to consider what method they want to use to first 
ventilate behind the obstructed units. Flutter uses a three second breath hold, Acapella 
like PEP increases FRC, splinting airways open. HFCWO needs to be combined with 
either deep inspiratory manoeuvres, three second breath hold, or PEP.  
f) Exhaling into ERV, as used during AD, Flutter and HFCWO assists in mobilising 
secretions from the small airways but has the potential to cause airway closure.
62,69,71
 To 
avoid this, during these techniques, the therapist should ensure patients adequately 
incorporate methods to ventilate small airways such as three second breath holds, or 
thoracic expansion exercises. 
g) A therapeutic strategy for an individual patient may involve a combination of ACTs. For 
example, in a patient with unstable large airways, the use of a PEP device will enhance 
ventilation. But during the huffing phase the airways may be unable to resist 
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compression. By combining PEP with AD, expiratory flow rates could be increased 
without causing airway compression thereby mobilising secretions more effectively 
Conclusion  
The approach to care of the individual patient needs to be personalised. Sometimes, in clinical 
practice more than one ACT may be effective for a patient at a given time in their disease 
trajectory and choice of technique may then be dependent on availability and patient preference. 
Other considerations include cleaning and durability of an ACT device if one is used. However, 
more often than not, due to the varying nature of the underlying disease pathology; phenotypic 
characteristics; and, taking into account individual patients’ clinical, functional, environmental 
and social factors, ACTs needs to be personalised to meet patient’s specific needs. This requires 
a sound understanding of the physiological basis of each technique 
Examining the application of physiological principles to ACTs provides a better understanding 
of how to optimise airway clearance strategies to the individual patient’s underlying pathology. 
This allows for both more personalised and improved patient care. Physiological theories which 
support ACTs had previously been identified.
42,43,86 
 However, this is the first review to present 
the physiological evidence supporting methods to ventilate behind obstructed lung units, and 
modulation of expiratory airflow, and to collate this physiological evidence in an effort to assist 
in translation into practice. 
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RE: manuscript ID ERR-0086-2016 R1 
Point by point response to reviewers. 
We thank the editors and reviewers for reviewing this paper. We hope we have addressed all the 
concerns expressed in this letter and have provided a point to point response to each concern 
Reviewer 3. Comments to the authors 
1.  Page 5, line 37: „…non-ventilated spontaneously BREATHING patient”. Add “…ly 
breathing” 
 
Response from authors 
Thank-you for your feedback and the manuscript has been changed to, “ spontaneously breathing 
patient both on line 37 and on page 3 line 47. 
 
Reviewer 3. Comments to the authors 
2. Page 5, line 41: This sentence is not quite correct. Airflow would be ventilating only those 
parts of the lungs where airways are not totally obstructed. This reviewer would suggest to add 
for example “with patent airways” after “…areas of the lung”. 
  
Response from authors 
The authors agree with the reviewer, that we are discussing partially obstructed airway, that is 
why the sentence states that, “secretions decrease the diameter of the airway ...” as opposed to 
totally obstructing an airway.  
The authors have also tried to clarify this sentence and the previous sentence by commencing the 
sentence following the one, “:areas of the lung... “with, “In patients with obstructed airways 
secretions..”  The authors have also added to the previous sentence, “In normal healthy 
individuals, during..” . This is to differentiate the difference between healthy and obstructed 
lungs. 
 
Reviewer 3. Comments to the authors 
3. Page 5, line 49: Time constants may change if the connections are opened more but most 
likely, the time itself is what counts. It is strongly suggested to delete “due to altered time 
constants”. 
 
Response from authors 
Thank-you for your feedback and as per the suggestion, the authors have deleted, “due to altered 
time constants”. 
Reviewer 3. Comments to the authors 
4. Page 6, line 54: delete the “s” in “exists”.  
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Response from authors 
Thank-you for your feedback and as per the suggestion, the authors have deleted the S in exists.  
 
Reviewer 3. Comments to the authors 
5. Page 9, line 39: the sentence “… excessive secretions down to …” may be misleading. 
Possibly, “…secretions FROM TRACHEA AND BROCHI down to…” is more clear. 
 
Response from authors 
Thank-you for y ur feedback and as per the suggestion, have added, “clear excessive secretions” 
from the trachea down...” 
 
Reviewer 3. Comments to the authors 
6. Page 9, line 51: It should read “adhesion” instead of “shear force”, right? 
 
Response from authors 
Thank-you for your feedback. Have restructured the sentence to the following, “During this time, 
dynamic compression of the airways occurs, resulting in an increase in velocity and kinetic 
energy which produces a shear force detaching mucus from the airway walls and enhancing the 
cephalic movement of mucus proximally up the airways.” 
Reviewer 3. Comments to the authors 
7. Page 11, line 12/13: again, shear force is the force that detaches mucus. It should be “adhesive 
strength” or some similar expression. 
Response from authors 
Thank-you for your feedback and as per the suggestion, have deleted shear force and changed to 
adhesive strength. 
Reviewer 3. Comments to the authors 
8. Page 17, line 15/16: the time constants will not allow for more time. The Notion of time 
constants may be deleted in this context. 
Response from authors 
Thank-you for your feedback. The authors have removed the words, “time constants” and  
rephrased the sentence to, “A three second breath hold is included at the end of inspiration. This 
increases alveolar gas mixing and decreases the inhomogeneity of ventilation.
36
 The authors have 
included a reference for this. 
Reviewer 3. Comments to the authors 
9. Page 23, line 27: “…ACTs need…”, delete the “s” in “needs”. 
 
Response from authors 
Thank-you for your feedback and as per the suggestion, the authors have deleted the S in needs.  
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Reviewer 3. Comments to the authors 
10. Page 23, line 35: “This allows…”, add an “s” to “allow”. 
 
Response from authors  
Thank-you for your feedback and as per the suggestion, the authors have added an to allow.  
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